Supplementary Table S3 from Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer
Authors:
- Peter SchmidPeter Schmid
- Cynthia X. MaCynthia X. Ma
- Yeon Hee ParkYeon Hee Park
- Simon LordSLSimon Lord
- Anne ArmstrongAAAnne Armstrong
- Seock-Ah ImSISeock-Ah Im
- Shin-Cheh ChenSCShin-Cheh Chen
- Ricardo FernandesRicardo Fernandes
- Jacek JassemJJJacek Jassem
- Piotr J. WysockiPWPiotr J. Wysocki
- Yen-Shen LuYLYen-Shen Lu
- Hwei-Chung WangHWHwei-Chung Wang
Open Access
- 14 August 2026
- other
- Published by American Association for Cancer Research (AACR)